Single Dose of Psychedelic Curbs Depression, But Study Raises Concerns
THURSDAY, Nov. 3, 2022 (HealthDay News) — A single psychedelic trip with psilocybin — the mind-altering component of magic mushrooms — appears to lift the fog of major depression in some hard-to-treat patients, a new clinical trial reports. A 25-milligram dose of a synthetic psilocybin compound called COMP360 caused aContinue Reading